¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"hypersensitivity reactions"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® hypersensitivity ÇÑ±Û °ú¹Î, ¿¹¹Î
¼³¸í   
  1. ¾î¶² ¾à¹°À̳ª Àڱؿ¡ ´ëÇÏ¿© °úÀ×¹ÝÀÀÀ» ³ªÅ¸³»´Â ¹æÇâÀ¸·Î ¹ÝÀÀ¼ºÀÌ º¯È­ÇÑ »óÅÂ. °ú¹Î¼º ¹ÝÀÀÀº ¸é¿ª¹ÝÀÀ¿¡ ÀÇÇÏ¿© »ý±â´Â º´Àû °úÁ¤À¸·Î, Áï½ÃÇü¹ÝÀÀ°ú Áö¿¬Çü¹ÝÀÀÀ¸·Î ºÐ·ùµÈ´Ù. ¶ÇÇÑ ´ÙÀ½ÀÇ 4ÇüÀ¸·Î ºÐ·ùµÇ±âµµ ÇÑ´Ù. IÇüÀº Áï½ÃÇü °ú¹Î¼º ¹ÝÀÀ(¿¹ÄÁ´ë anaphylaxis). IIÇüÀº Á¶Á÷Ç׿ø¿¡ ´ëÇÑ Ç×ü¿¡ ÀÇÇÏ¿© »ý±â´Â ¼Õ»ó(¿¹ÄÁ´ë ÄáÆÏµ¶¼º ÄáÆÏ¿°). IIIÇüÀº Ç׿øÇ×üº¹ÇÕ¹°, Æ¯È÷ ¾à°£ÀÇ Ç׿øÀÇ °úÀ׿¡ ÀÇÇÏ¿© Çü¼ºµÇ´Â ¿ëÇØ¼º º¹ÇÕ¹°¿¡ ÀÇÇÏ¿© »ý±â´Â °Í(¿¹ÄÁ´ë ¾Æ¸£Åõ½º ¹ÝÀÀÀ̳ª Ç÷ûº´). IVÇüÀº Áö¿¬Çü °ú¹Ì¼º ¹ÝÀÀ(¿¹ÄÁ´ë Á¢Ã˼º ÇǺκ´)ÀÌ´Ù. 2. °¨°¢À̳ª °¨Á¤ÀÌ Áö³ªÄ¡°Ô ¿¹¹ÎÇÔ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antibody-mediated hypersensitivity
    Ç×ü¸Å°³°ú¹Î¼º
  • atopic hypersensitivity
    ¾ÆÅäÇǰú¹Î¼º
  • contact hypersensitivity
    Á¢Ã˰ú¹Î(Áõ)
  • cutaneous basophil hypersensitivity
    ÇǺÎÈ£¿°±¸°ú¹Î(Áõ)
  • cytotoxic hypersensitivity
    ¼¼Æ÷µ¶¼º°ú¹Î¼º
  • cell-mediated hypersensitivity
    ¼¼Æ÷¸Å°³°ú¹Î¼º
  • delayed-type hypersensitivity
    Áö¿¬°ú¹Î(¼º)
  • denervation hypersensitivity
    Å»½Å°æ°ú¹Î¼º
  • dermal hypersensitivity
    ÇǺΰú¹Î¼º
  • hypersensitivity
    1. °ú¹Î(¼º) 2. °ú¹Î(Áõ)
  • hypersensitivity angitis
    °ú¹Î¸Æ°ü¿°
  • hypersensitivity disorder
    °ú¹ÎÁúȯ
  • hypersensitivity myocarditis
    °ú¹Î½É±Ù¿°
  • hypersensitivity reaction
    °ú¹Î¹ÝÀÀ
  • hypersensitivity vasculitis
    °ú¹ÎÇ÷°ü¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypersensitivity
    °ú¹Î
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antibody-mediated hypersensitivity
    Ç×ü¸Å°³°ú¹Î
  • atopic hypersensitivity
    ¾ÆÅäÇǰú¹Î
  • cell-mediated hypersensitivity
    ¼¼Æ÷¸Å°³°ú¹Î
  • contact hypersensitivity
    Á¢Ã˰ú¹Î
  • cutaneous basophil hypersensitivity
    ÇǺÎÈ£¿°±¸°ú¹Î
  • cytotoxic hypersensitivity
    ¼¼Æ÷µ¶¼º°ú¹Î
  • delayed-type hypersensitivity
    Áö¿¬°ú¹Î
  • denervation hypersensitivity
    ½Å°æÁ¦°Å°ú¹Î
  • denervation hypersensitivity test
    Å»½Å°æ°ú¹Î¹ÝÀÀ°Ë»ç
  • dermal hypersensitivity
    ÇǺΰú¹Î
  • hypersensitivity disorder
    °ú¹ÎÁúȯ
  • hypersensitivity
    °ú¹Î
  • hypersensitivity angitis
    °ú¹Î¸Æ°ü¿°
  • hypersensitivity myocarditis
    °ú¹Î½É±Ù¿°
  • hypersensitivity reaction
    °ú¹Î¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypersensitivity reactions
    °ú¹Î¼º ¹ÝÀÀ(ΦÚÂàõ Úãëë)
  • hypersensitivity reactions,delayed-type
    Áö¿¬Çü(òÀæÅû¡)
  • hypersensitivity reactions,type i(anaphylactic)
    IÇü
  • hypersensitivity reactions,type ii(antibody-dependent cell-mediate cyt
    IIÇü
  • hypersensitivity reactions,type iii(imune complex-mediated)
    IIIÇü
  • hypersensitivity reactions,type iv(cell-mediated)
    IVÇü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Hemolytic transfusion reactions
    ¿ëÇ÷¼º ¼öÇ÷¹ÝÀÀ(âÃúìÚãëë)
  • adverse reactions
    ºÎÀÛ¿ë
  • hemolytic transfusion reactions
    ¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
  • angiitis,hypersensitivity
    °ú¹Î¼º(ΦÚÂàõ)
  • antibody-mediated hypersensitivity
    Ç×ü¸Å°³ °ú¹Î¹ÝÀÀ
  • gluten hypersensitivity
    ±Û·çÅÙ°ú¹Î¹ÝÀÀ
  • hypersensitivity
    °ú¹Î¼º
  • hypersensitivity
    °¨°¢°ú¹Î¼º
  • hypersensitivity =hypersensitiveness
    °ú¹Î¼º, °ú¹ÎÁõ.
  • hypersensitivity angitis
    °ú¹Î¼º ¸Æ°ü¿°.
  • hypersensitivity angitis
    °ú¹Î¼º Ç÷°ü¿°(ΦÚÂàõ úìηæú)
  • hypersensitivity disorders
    °ú¹Î¼º Áúȯ(ΦÚÂàõ òðü´)
  • hypersensitivity myocarditis
    °ú¹Î¼º ½É±Ù¿°.
  • hypersensitivity pneumonia
    °ú¹Î¼º Æó·Å.
  • hypersensitivity reaction
    °ú¹Î¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypersensitivity reactions
    °ú¹Î¼º ¹ÝÀÀ(ΦÚÂàõ Úãëë)
  • hypersensitivity reactions,delayed-type
    Áö¿¬Çü(òÀæÅû¡)
  • hypersensitivity reactions,type i(anaphylactic)
    IÇü
  • hypersensitivity reactions,type ii(antibody-dependent cell-mediate cyt
    IIÇü
  • hypersensitivity reactions,type iii(imune complex-mediated)
    IIIÇü
  • hypersensitivity reactions,type iv(cell-mediated)
    IVÇü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adverse reactions
    ºÎÀÛ¿ë
  • autoimmune reactions
    ÀÚ°¡¸é¿ª¹ÝÀÀ(í»Ê«Øóæ¹Úãëë).
  • bereavement reactions
    ¾Öµµ¹ÝÀÀ
  • circular reactions
    ¼øÈ¯¹ÝÀÀ(âàü»Úãëë)
  • delayed hemolytic transfusion reactions
    Áö¿¬¼º¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
  • donor reactions
    ÇåÇ÷ÀÚ ¹ÝÀÀ
  • drug reactions, adverse
    ¾à¹°¹ÝÀÀ(¡­Úãëë), ºÎÀÛ¿ë(ÜùíÂéÄ)
  • free radical formation,redox reactions
    ÀÚÀ¯ ·¡µðÄ® Çü¼º, »êȭȯ¿ø¹ÝÀÀ(ß«ûùü½êªÚãëë)
  • hemolytic transfusion reactions
    ¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
  • mixed-field reactions
    È¥Çսþ߹ÝÀÀ
  • nonimmunologic febrile transfusion reactions
    ºñ¸é¿ª¼º ¹ß¿­¼öÇ÷¹ÝÀÀ
  • nonimmunologic hemolytic transfusion reactions
    ºñ¸é¿ª¼º¿ëÇ÷¼öÇ÷¹ÝÀÀ
  • transfusion reactions
    ¼öÇ÷¹ÝÀÀ, ¼öÇ÷ºÎÀÛ¿ë
  • angiitis,hypersensitivity
    °ú¹Î¼º(ΦÚÂàõ)
  • antibody-mediated hypersensitivity
    Ç×ü¸Å°³ °ú¹Î¹ÝÀÀ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • browning reactions
    °¥º¯¹ÝÀÀ(ÊèܨÚãëë)
  • coenzyme-coupled reactions
    º¸È¿¼Ò(ÜÍý£áÈ)¦Áö¿ò ¹ÝÀÀ
  • consecutive reactions
    ¿¬¼Ó ¹ÝÀÀ(Ö§áÙÚãëë)
  • coupled reactions
    "°ø¿ª¹ÝÀÀ(ÍëæµÚãëë), ¦Áø¹ÝÀÀ"
  • energetically coupled reactions
    ¿¡³ÊÁö ¦Áø ¹ÝÀÀ(Úãëë)
  • linked reactions
    ¿¬°è¹ÝÀÀ(ͨͧÚãëë)
  • antibody mediated hypersensitivity
    Ç×ü ¸Å°³ °ú¹ÎÁõ(ù÷ô÷ØÚ˿ΦÚÂñø)
  • contact hypersensitivity
    Á¢Ã˰ú¹ÎÁõ(ïÈõºÎ¦ÚÂñø)
  • delayed-type hypersensitivity
    Áö¿¬Çü °ú¹ÎÁõ(òÀæÅû¡Î¦ÚÂñø)
  • hypersensitivity
    °ú¹Î¼º(ΦÚÂàõ)
  • immediate-type hypersensitivity
    Áï½ÃÇü °ú¹ÎÁõ(ñíãÁúþΦÚÂñø)
  • induced hypersensitivity
    À¯µµ°ú¹ÎÁõ(ë¯ÓôΦÚÂñø)
  • spontaneous hypersensitivity
    ÀÚ¿¬ °¨¼ö¼º(í»æÔÊïáôàõ)
  • tuberculin hypersensitivity
    Åõº£¸£Ä𸰠°ú¹Î¼º(ΦÚÂàõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypersensitivity
    °ú¹Î¼º, °ú¹ÎÁõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HP Hypersensitivity Pneumonitis
  = Extrinsic Allergic Alveolitis
CBH chronic benign hepatitis; cutaneous basophilic hypersensitivity
CHS central hypoventilation syndrome; Chediak-Higashi syndrome; cholinesterase; chondroitin sulfate; com...
CSH carotid sinus hypersensitivity; chronic subdural hematoma; combat support [army] hospital; cortical ...
DCH delayed cutaneous hypersensitivity; Diploma in Child Health
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DHR Delayed hypersensitivity reactions
HSR Hypersensitivity reactions
AR Anaphylactoid reactions
CSR Combat stress reactions
HTR Hemolytic transfusion reactions
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cell-mediated hypersensitivity
    ¼¼Æ÷ ¸Å°³¼º °ú¹ÎÁõ
    TuberculinÇü Çdz» ¹ÝÀÀÀ» ´ëÇ¥·Î ÇÑ´Ù. ¼¼Æ÷¼º ¸é¿ª ¹ÝÀÀÀÇ ÇÑ ÇüÅÂ. Ç׿ø¿¡ ÀÇÇÏ¿© °¨ÀÛµÈ µ¿¹°ÀÇ Çdz»¿¡ ÀçÂ÷ Ç׿øÀ» ÁÖ»çÇÔÀ¸·Î½á ¼ö ½Ã°£À¸·ÎºÎÅÍ 36½Ã°£ ÈÄ¿¡ ¹ßÀû, °æ°áÀ» ¼ö¹Ý½ÃŰ´Â Á¾Ã¢ÀÌ ÁÖ»ç ºÎÀ§¿¡ ¹ß»ýÇÏ´Â ¹ÝÀÀÀÌ´Ù.
  • cellular hypersensitivity
    ¼¼Æ÷¼º °ú¹Î¹ÝÀÀ
    ¼¼Æ÷¿¡ ´ëÇÏ¿© °úÀ×¹ÝÀÀÀ» ³ªÅ¸³»´Â ¹æÇâÀ¸·Î ¹ÝÀÀ¼ºÀÌ º¯È­ÇÑ »óÅÂ.
  • cutaneous hypersensitivity
    ÇǺΠ°ú¹ÎÁõ
  • delayed hypersensitivity
    Áö¿¬Çü °ú¹Î¼º
  • denervation hypersensitivity test
    Å»½Å°æ °ú¹Î ¹ÝÀÀ °Ë»ç
  • ensitization 1. administration of antigen to induce a primary immune response; priming; immunization. 2. exposure to allergen that results in the development of hypersensitivity. 3. the coating of erythrocytes with antibody so that they are subject to lys
    ³»¹ø
    ƯÈ÷ ¾È°Ë ¿¬ÀÇ.
  • hypersensitivity angitis
    °ú¹Î¼º ¸Æ°ü¿°
  • immediate hypersensitivity
    Áï½Ã °ú¹ÎÁõ, Áï½ÃÇü °ú¹ÎÁõ, Áï°¢ °ú¹Î ¹ÝÀÀ
    ¹Ì¸® ƯÁ¤ÀÇ Ç׿ø¿¡ ÀÇÇÏ¿© °¨À۵ǰí ÀÖ´Â »ýü°¡ µ¿ÀÏ Ç׿øÀÇ 2ȸ ° ÀÌÈÄÀÇ Åõ¿©¿¡ ÀÇÇÏ¿© Á¤»óº¸´Ù °ú¹ÎÇÑ ¹ÝÀÀÀ» ÀÏÀ¸Å²´Ù. À̶§ÀÇ ¹ÝÀÀÀ¸·Î ÀÌ Ç׿ø°ú »ýü ³»¿¡ »ý»êµÈ Ç×ü¿¡ ÀÇÇÏ¿© ƯÀÌÀûÀÎ °áÇÔÀÌ ÀϾ »ýüÁ¶Á÷¿¡ Àå¾Ö¸¦ ÀÏÀ¸Å²´Ù.
  • streptococcal hypersensitivity
    ¿¬¼â ±¸±Õ °ú¹Î¼º
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
gel diffusion reactions Precipitin test's in which the immune precipitate forms in a gel medium (usually agar) into which one or both reactants have diffused; generally classified in two types, in one dimension, and in two dimensions.
Synonym: gel diffusion reactions.
(05 Mar 2000)
positive supporting reactions Consisting of those reflex muscular contractions whereby the body is supported against gravity; seen in an exaggerated form in the decerebrate animal, negative supporting reaction's, consisting of inhibition of the extensor muscles and unfixing of the joints which thus enable the limb to be flexed and moved into a new position.
Synonym: supporting reflexes.
(05 Mar 2000)
half-reactions <chemistry> The two parts of an oxidation-reduction reaction, one representing oxidation, the other reduction.
(09 Jan 1998)
supporting reactions Described by Magnus, who distinguished two types:
(05 Mar 2000)
light reactions In photosynthesis, aseries of reactions in which light energy isconverted to chemical energy with the help of chlorophyll. ATP iscreated along with hydrogen ions and electrons as water molecules aresplit apart.
(09 Oct 1997)
vasculitis, hypersensitivity Heterogeneous group of disorders characterised by a vasculitic syndrome presumed to be associated with a hypersensitivity reaction following exposure to an antigen such as an infectious agent, a drug, or other foreign or endogenous substance.
(12 Dec 1998)
respiratory hypersensitivity A form of hypersensitivity affecting the respiratory tract. It includes asthma and hay fever.
(12 Dec 1998)
milk hypersensitivity Allergic reaction to milk (usually cow's milk) or milk products. In infants the hypersensitivity is manifested by colic, vomiting, diarrhoea, rhinitis, wheezing, etc. Milk hypersensitivity should be differentiated from lactose intolerance, an intolerance to milk as a result of congenital deficiency of lactase.
(12 Dec 1998)
contact hypersensitivity <pathology> A type of immune-mediated inflammatory skin rash that results from an allergy to a particular substance (for example jewelry dermatitis, poison ivy, neomycin ointment, etc.).
(27 Sep 1997)
hypersensitivity <immunology> A state of altered reactivity in which the body reacts with an exaggerated immune response to a foreign substance. Hypersensitivity reactions are classified as immediate or delayed, types I and IV, respectively, in the Gell and Coombs classification of immune responses.
(18 Nov 1997)
hypersensitivity, delayed An increased reactivity to specific antigens mediated not by antibodies but by cells.
(12 Dec 1998)
hypersensitivity, immediate Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability.
(12 Dec 1998)
hypersensitivity pneumonitis <radiology> Aka: chronic extrinsic allergic alveolitis, pathology: proliferation of epithelial cells, elaboration of reticulum fibres, findings: interstitial reticulonodular pattern (basilar distribution), volume loss (cicatrization atelectasis) in upper lobes, pleural effusion (rare), lymph node enlargement may occur
(12 Dec 1998)
hypersensitivity reaction <immunology> The bodys response to an allergic stimulus. This can be localised to one area or generalised and may include: rash, itching, hives, swelling, difficulty breathing, and/or low blood pressure.
(27 Sep 1997)
hypersensitivity vasculitis An acute form of vasculitis which may affect the skin only, but also may involve other organs, with a polymorphonuclear infiltrate in the walls of and surrounding small (dermal) vessels. Nuclear fragments are formed by karyorrhexis of the neutrophils.
See: leukocytoclastic vasculitis.
Synonym: allergic angiitis, hypersensitivity vasculitis.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypersensitivity
    °ú¹ÎÁõ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á